Company Overview and News

 
Premier Investments profit falls 20 per cent on fashion write-downs

2018-09-19 theage.com.au
Retail group Premier Investments has reported a 20 per cent slump in full-year net profit, after writing down the value of some of its fashion brands in recognition of the "increasingly competitive" apparel retail landscape.
PMV

 
Premier Investments profit falls 20 per cent on fashion write-downs

2018-09-19 smh.com.au
Retail group Premier Investments has reported a 20 per cent slump in full-year net profit, after writing down the value of some of its fashion brands in recognition of the "increasingly competitive" apparel retail landscape.
PMV

 
Two men with grenades: Who'll be the first to pull pin in Myer fight?

2018-09-19 theage.com.au
Make no mistake, in buying 5 per cent of Myer profile investor Geoff Wilson has bought into a dangerous battle with the department store's largest shareholder, Solomon Lew. Trouble for Wilson is that he may have brought a knife to a gun fight.
PMV

 
Two men with grenades: Who'll be the first to pull pin in Myer fight?

2018-09-19 smh.com.au
Make no mistake, in buying 5 per cent of Myer profile investor Geoff Wilson has bought into a dangerous battle with the department store's largest shareholder, Solomon Lew. Trouble for Wilson is that he may have brought a knife to a gun fight.
PMV

 
Solly Lew tries to recruit major Myer player to join insurgency

2018-09-17 theage.com.au
Billionaire retailer Solomon Lew has tried to enlist the newly minted, third major force on Myer's share registry into his corporate insurgency, saying he would be surprised if Geoff Wilson could support the department store's current directors "given their appalling track record".
PMV 8956

 
Solly Lew tries to recruit major Myer player to join insurgency

2018-09-17 smh.com.au
Billionaire retailer Solomon Lew has tried to enlist the newly minted, third major force on Myer's share registry into his corporate insurgency, saying he would be surprised if Geoff Wilson could support the department store's current directors "given their appalling track record".
PMV 8956

 
Myer shares soar 40pc as investors digest new strategy

2018-09-13 theage.com.au
Myer's share price soared almost 40 per cent on Thursday, a day after it revealed a near half-billion dollar loss, as investors digested a refinancing of its debt and its new boss' plan to return the business to health.
PMV

 
Myer shares soar 40pc as investors digest new strategy

2018-09-13 smh.com.au
Myer's share price soared almost 40 per cent on Thursday, a day after it revealed a near half-billion dollar loss, as investors digested a refinancing of its debt and its new boss' plan to return the business to health.
PMV

 
Myer boss outlines revival plan as investors reel from $486m loss

2018-09-12 theage.com.au
Myer's new boss John King has outlined his plan to return the iconic department store to growth by reclaiming "heartland Australia" and ending the company's history of "poor execution" which on Wednesday culminated in it diving to a full-year loss of almost half a billion dollars.
PMV

 
Myer boss outlines revival plan as investors reel from $486m loss

2018-09-12 smh.com.au
Myer's new boss John King has outlined his plan to return the iconic department store to growth by reclaiming "heartland Australia" and ending the company's history of "poor execution" which on Wednesday culminated in it diving to a full-year loss of almost half a billion dollars.
PMV

 
'Absolute disgrace': Solly Lew slams Myer after $486 million loss

2018-09-12 theage.com.au
Billionaire retailer Solomon Lew has renewed his attack on Myer's board after the iconic retailer fell to an almost half-billion dollar loss, and has demanded that chairman Garry Hounsell stand down or risk getting booted by angry shareholders.
PMV

 
'Absolute disgrace': Solly Lew slams Myer after $486 million loss

2018-09-12 smh.com.au
Billionaire retailer Solomon Lew has renewed his attack on Myer's board after the iconic retailer fell to an almost half-billion dollar loss, and has demanded that chairman Garry Hounsell stand down or risk getting booted by angry shareholders.
PMV

 
Retail sun shines as Brighton shop sells for $8.2m

2018-08-14 theage.com.au
In the heartland of Melbourne’s blue chip suburb of Brighton, a stark contrast in suburban retail fortunes has unfolded.
PMV

 
Retail sun shines as Brighton shop sells for $8.2m

2018-08-14 smh.com.au
In the heartland of Melbourne’s blue chip suburb of Brighton, a stark contrast in suburban retail fortunes has unfolded.
PMV

 
Four things that can save Myer

2018-07-27 ntnews.com.au
Former CEO of UK based department store 'House of Fraser' has been appointed as the new CEO of struggling retailer Myer.
PMV

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:PMV / PREMIER INVESTMENTS LIMITED on message board site Silicon Investor.

PMV.V PMV.V PMV.V